NO20003344L - Topiske øyepreparater inneholdende immunosuppressive midler - Google Patents

Topiske øyepreparater inneholdende immunosuppressive midler

Info

Publication number
NO20003344L
NO20003344L NO20003344A NO20003344A NO20003344L NO 20003344 L NO20003344 L NO 20003344L NO 20003344 A NO20003344 A NO 20003344A NO 20003344 A NO20003344 A NO 20003344A NO 20003344 L NO20003344 L NO 20003344L
Authority
NO
Norway
Prior art keywords
weight
hydroxy
ethanediyl
oxy
poly
Prior art date
Application number
NO20003344A
Other languages
English (en)
Other versions
NO20003344D0 (no
Inventor
Milan Stuchlik
Alexandr Jegorov
Vladimir Matha
Josef Stuchlik
Original Assignee
Galena As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galena As filed Critical Galena As
Publication of NO20003344L publication Critical patent/NO20003344L/no
Publication of NO20003344D0 publication Critical patent/NO20003344D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det beskrives terapeutiske preparater for topisk oftalmisk påføring, inne- holdende fra 0,02 til 5,0 vekt% immunsuppressive midler tilhørende gruppen av monocykliske undekapeptider, makrolid-laktoner eller kortikosteroider, i en bærer omfattende opp til 10 vekt% polyalkylenglykol-polyuretan-kopolymerer. Nevnte kopolymerer består fortrinnsvis av poly(oksy-1,2-etandiyl)-a-hydro-o>- hydroksypolymerer med 1,1'-metylen-bis-(4-isocyanatcykloheksan) som har en gjennomsnittlig molekylvekt på fra 1000 til 3000 i en hydrofil bærer og fortrinnsvis av poly[oksy-(metyl-1,2-etandiyl)]-a-hydro-co-hydroksypolymerer med 1,1 '-metylen-bis- (4-isocyanatcykloheksan) som har en gjennomsnittlig molekylvekt på'fra 1600 til ¿ 18000 i en lipofil bærer. Nevnte terapeutiske midler kan dessuten inneholde hjelpestoffer som er vanlige i topiske administrasjonsformer.
NO20003344A 1997-12-30 2000-06-27 Topiske øyepreparater inneholdende immunosuppressive midler NO20003344D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ19974237A CZ287497B6 (cs) 1997-12-30 1997-12-30 Topické oční přípravky s imunosupresivními látkami
PCT/CZ1998/000054 WO1999034830A1 (en) 1997-12-30 1998-12-17 Topical ophthalmic preparations containing immunosuppressive agents

Publications (2)

Publication Number Publication Date
NO20003344L true NO20003344L (no) 2000-06-27
NO20003344D0 NO20003344D0 (no) 2000-06-27

Family

ID=5467853

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003344A NO20003344D0 (no) 1997-12-30 2000-06-27 Topiske øyepreparater inneholdende immunosuppressive midler

Country Status (12)

Country Link
EP (1) EP1058560A1 (no)
JP (1) JP2002500200A (no)
AU (1) AU1481399A (no)
BG (1) BG104558A (no)
CA (1) CA2317010A1 (no)
CZ (1) CZ287497B6 (no)
HR (1) HRP20000258A2 (no)
HU (1) HUP0004173A2 (no)
NO (1) NO20003344D0 (no)
PL (1) PL341604A1 (no)
SK (1) SK284246B6 (no)
WO (1) WO1999034830A1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ513111A (en) * 1998-12-24 2003-10-31 R Tech Ueno Ltd Agent for treating visual cell function disorder
US6864232B1 (en) 1998-12-24 2005-03-08 Sucampo Ag Agent for treating visual cell function disorder
TWI324925B (en) * 2001-08-23 2010-05-21 Novartis Ag Ophthalmic composition
DK1539157T3 (da) 2002-09-18 2013-10-07 Univ Pennsylvania Fremgangsmåde til hæmning af choroidal neovaskularisering
US7354574B2 (en) 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
US7083802B2 (en) * 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
KR20060085246A (ko) 2003-09-18 2006-07-26 마커사이트, 인코포레이티드 경공막 전달
US7087237B2 (en) 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
US7083803B2 (en) 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
DK1848431T3 (en) 2005-02-09 2016-04-18 Santen Pharmaceutical Co Ltd LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS
EP1904056B1 (en) 2005-07-18 2009-04-29 Minu, L.L.C. Use of a macrolide to restore corneal sensation
KR20140093764A (ko) 2006-02-09 2014-07-28 산텐 세이야꾸 가부시키가이샤 안정한 제제와 그 제조 및 사용 방법
ES2563288T3 (es) 2006-03-23 2016-03-14 Santen Pharmaceutical Co., Ltd Rapamicina en dosis bajas para el tratamiento de enfermedades relacionadas con la permeabilidad vascular
AU2014209141B2 (en) 2013-01-24 2018-05-10 Palvella Therapeutics, Inc. Compositions for transdermal delivery of mTOR inhibitors
HK1216146A1 (zh) * 2013-03-27 2016-10-21 Comprehensive Drug Enterprises, Ltd. 眼药组合物、其制备方法及用途
AU2017229125B2 (en) 2016-03-08 2021-07-29 Living Proof, Inc. Long lasting cosmetic compositions
EP3565520B1 (en) 2017-01-06 2026-02-25 Palvella Therapeutics, Inc. Anhydrous compositions of mtor inhibitors and methods of use
AU2018333932B2 (en) 2017-09-13 2024-05-02 Living Proof, Inc. Long lasting cosmetic compositions
EP3681921A2 (en) 2017-09-13 2020-07-22 Living Proof, Inc. Color protectant compositions
CN111356501A (zh) 2017-11-20 2020-06-30 生活实验公司 实现持久化妆品性能的属性
BR112020021902B1 (pt) 2018-04-27 2024-02-20 Living Proof, Inc Composições cosméticas de poliuretano-ureia para tratamento capilar, método de preservação da ondulação no cabelo humano e os usos de poliuretano-ureia
US11000513B2 (en) 2018-07-02 2021-05-11 Palvella Therapeutics, Inc. Anhydrous compositions of mTOR inhibitors and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051260A (en) * 1987-07-16 1991-09-24 The Regents Of The University Of California Method and composition for enhancing the cutaneous penetration of pharmacologically active agents
US4971800A (en) * 1988-07-08 1990-11-20 The Regents Of The University Of California Method and compositions for enhancing the cutaneous penetration of pharmacologically active agents
US5045317A (en) * 1987-07-16 1991-09-03 The Regents Of The University Of California Enhancing the cutaneous penetration of pharmacologically active agents

Also Published As

Publication number Publication date
CZ423797A3 (cs) 1999-07-14
EP1058560A1 (en) 2000-12-13
AU1481399A (en) 1999-07-26
WO1999034830A1 (en) 1999-07-15
NO20003344D0 (no) 2000-06-27
SK284246B6 (sk) 2004-12-01
CA2317010A1 (en) 1999-07-15
HUP0004173A2 (hu) 2001-08-28
CZ287497B6 (cs) 2000-12-13
HRP20000258A2 (en) 2001-04-30
SK171798A3 (en) 1999-10-08
JP2002500200A (ja) 2002-01-08
PL341604A1 (en) 2001-04-23
BG104558A (en) 2001-02-28

Similar Documents

Publication Publication Date Title
NO20003344L (no) Topiske øyepreparater inneholdende immunosuppressive midler
CA2231886A1 (en) Copolymeric micelle drug composition and method for the preparation thereof
CA2308520A1 (en) Strictly alternating poly(alkylene oxide ether) copolymers
CA2256390A1 (en) Vitamin c delivery system
ATE181936T1 (de) Wässrige polyurethanzubereitungen
DK1531800T3 (da) Stealth-lipidnanokapsler, fremgangsmåder til fremstilling deraf som en bærer for aktivt princip(per)
ES551372A0 (es) Procedimiento para preparar una dispersion acuosa estable, congelada, de un copolimero y una droga. (como desglose y con prioridad de la patente espanola no. 544.580, presentada el 26 de junio de 1.985).
DE69424275D1 (de) Alkalische ophthalmische suspensionen
WO1999002186A3 (en) Antigen delivery system comprising monoglyceride or diglyceride derivatives as adjuvant
CA2271139A1 (en) Percutaneous delivery system
WO2002053100A3 (en) Pharmaceutical dosage form for oral administration of low molecular weight heparin
NZ336462A (en) Pharmaceutical composition of fenofibrate with high biological availability
AU5154999A (en) A method for stimulating the immune system
CA2177683A1 (en) Tissue Moisturizing and Antimicrobial Compositions
WO2002043736A1 (en) Beautifying foods and drinks and peroral beautifying preparations
CA2336149A1 (en) A membrane or matrix for controlling the permeation rate of drugs
NO20006631L (no) Forbindelser oppnådd fra salvie-arter med antiviral aktivitet
PL311698A1 (en) Preparations in the form of solid solutions
WO2003020235A3 (de) Stabilisierung oxidations- und/oder uv-empfindlicher wirkstoffe
WO2024192323A3 (en) Ophthalmic cream formulations and their uses
EP0354714A3 (en) Pharmaceutical compositions containing polyaromatic compounds
EP1127575A3 (en) Ocular tissue regeneration inducer
Wang et al. Oxygen permeability of biodegradable copolycaprolactones
RU2000120201A (ru) Глазные препараты для местного применения, содержащие иммуносупрессивные агенты
EP0992242A4 (en) PROPHYLACTIC AGENTS AND / OR REMEDIES CONTAINING VITAMIN D FOR PREVENTING AND / OR TREATING CONJUNCTIVAL / CORNEAL XEROSIS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application